Below is an important notice from Independence Blue Cross regarding Medicare Part D notification requirement for 2025-2026
Dear Valued Benefits Administrator:
As you may know, employers that offer prescription drug coverage to their Medicare-eligible employees, retirees, and dependents (collectively referred to as “members”) must notify them by October 15, 2025 of whether that coverage is “creditable” or “non-creditable.” We are writing to remind you that requirement and to provide you with information on the statues of Independence Blue Cross (Independence) prescription drug plans.
This Requirement is Part of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), which added a new prescription drug program to Medicare known as the Part D drug benefit. Under the MMA, the Centers for Medicare & Medicaid Services (CMS) established two categories of prescription drug coverage drug benefit that has an actuarial value as good as or better than the standard Part D drug benefit. A non-creditable prescription drug plan has an actuarial value that is not as good as the standard Part D drug benefit.
Plan Creditability for 2025 and 2026
Small Group
All of our prescription drug plans offered with our Qualified Health Plans are creditable for 2025 and will be for 2026.
Large Group
All of our standard prescription drug plans offered with our health plans are creditable for 2025 as well as those listed 2026. The enclosed chart shows our 2026 standard prescription drug plans.
Important: If your group has a plan that is not a standard plan shown on the chart and you would like us to test it to determine if it is creditable or non-creditable, please contact your Independence account executive, broker, or consultant.